Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C

A Bayram1, F Eksi, M Mehli

  • 1Department of Microbiology and Clinical Microbiology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey. aysenbayram@hotmail.com

Intervirology
|June 16, 2007
PubMed

Insights

Hepatitis E virus (HEV) infection is significantly more common in patients with chronic hepatitis C virus (HCV) than in those with chronic hepatitis B virus (HBV) or healthy individuals. This suggests a shared transmission route and highlights the need for HEV prevention in HCV patients.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant global health concerns.
  • Hepatitis E virus (HEV) is an emerging pathogen with various genotypes and transmission routes.

Purpose of the Study:

  • To determine the prevalence of HEV infection in patients with chronic HBV and chronic HCV.
  • To compare HEV prevalence between chronic hepatitis patients and a control group.

Main Methods:

  • Serum samples were collected from 190 chronic HBV patients, 174 chronic HCV patients, and 178 healthy controls.
  • Anti-HEV IgG antibodies were detected using serological assays.

Main Results:

  • HEV IgG positivity was 13.7% in chronic HBV patients and 54% in chronic HCV patients.
  • The control group showed 15.7% anti-HEV IgG positivity.
  • HEV infection prevalence was significantly higher in chronic HCV patients compared to chronic HBV patients and controls.

Conclusions:

  • HEV and HCV may share common transmission routes, particularly in the studied region.
  • Chronic HCV patients are at higher risk for HEV superinfection.
  • Preventive measures against HEV are recommended for chronic HCV patients due to potential for severe disease patterns.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...